(45) demonstrated that elevated NOS2 expression has been shown to reduce tumorigenicity in vivo and inhibit CRC cell proliferation and survival by inducing apoptosis through suppression of the NF-κB signaling pathway. Here, NOS2 is linked to colorectal carcinoma.